Dilepix is currently owned by Elaia Partners, through Elaia Alpha II, since 2020.

When did Elaia Partners acquire Dilepix?

Elaia Partners acquired Dilepix in 2020 (active for 6 years).

Dilepix

Biotech·

France·Active·6yr hold

Dilepix is a biotechnology company, headquartered in France.

Entry

2020

Hold

6yr

Status

Active

Est. EV

–

Investor

HQFrance

SectorBiotechnology

Dilepix provides farmers with software solutions for monitoring crops and livestock using cameras and artificial intelligence.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Full fund context: vintage, strategy, region

6 portfolio peers in Elaia Alpha II

6 comparable biotech deals from other GPs

Already a member? Sign in

Data refreshed weekly · Sourced from public filings